التفاصيل البيبلوغرافية
| العنوان: |
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib TD-0903 in severe COVID-19 |
| المؤلفون: |
Singh, D., Boguş, M., Moskalenko, V., Noi, A. |
| المصدر: |
European Respiratory Journal 0-0 |
| سنة النشر: |
2021 |
| مصطلحات موضوعية: |
MeSH Administration, inhalation, COVID-19, Humans, Janus Kinase Inhibitors, Janus Kinases, SARS-CoV-2 EMTREE drug terms advanced glycation end product receptor, C reactive protein, dexamethasone, heparin, nezulcitinib, placebo, remdesivir, Janus kinase, Janus kinase inhibitor EMTREE medical terms adult, arterial oxygen saturation, clinical article, controlled study, coronavirus disease 2019, double blind procedure, drug dose escalation, drug dose increase, drug safety, drug tolerability, drug withdrawal, female, fraction of inspired oxygen, human, hypertransaminasemia, invasive ventilation |
| نوع الوثيقة: |
article in journal/newspaper |
| وصف الملف: |
application/pdf |
| اللغة: |
English |
| تدمد: |
09031936 |
| Relation: |
https://ibn.idsi.md/vizualizare_articol/185071; urn:issn:09031936 |
| DOI: |
10.1183/13993003.00673-2021 |
| الاتاحة: |
https://ibn.idsi.md/vizualizare_articol/185071
https://doi.org/10.1183/13993003.00673-2021 |
| Rights: |
info:eu-repo/semantics/openAccess |
| رقم الانضمام: |
edsbas.1BA9CD78 |
| قاعدة البيانات: |
BASE |
Full Text Finder